Implanted bronchial isolation devices and methods

Abstract

Disclosed are methods and devices for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and / or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and / or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region.

Description

CROSS-REFERENCES TO RELATED APPLICATIONS[0001]This application is a continuation-in-part of co-pending application Ser. No. 11 / 075,633, filed on Mar. 8, 2005, which claimed priority from U.S. Provisional Patent Application Ser. No. 60 / 551,476 filed Mar. 8, 2004. This application is also a continuation-in-part of co-pending application Ser. No. 12 / 264,849, filed on Nov. 4, 2008, which was a continuation of application Ser. No. 11 / 395,396, filed on Mar. 30, 2006, now U.S. Pat. No. 7,662,181, which was a continuation of application Ser. No. 10 / 630,473, filed on Jul. 29, 2003, now U.S. Pat. No. 7,165,548, which was a continuation of application Ser. No. 09 / 519,735, filed on Mar. 4, 2000, now U.S. Pat. No. 6,679,264. The complete disclosure of each listed application are hereby incorporated by reference.BACKGROUND OF THE INVENTION[0002]Pulmonary diseases, such as chronic obstructive pulmonary disease, (COPD), reduce the ability of one or both lungs to fully expel air during the exhalatio...

AI Technical Summary

Benefits of technology

[0010]In another aspect, there is described a fluid flow control device suitable for implanting in a bronchial passageway, comprising: a frame configured to retain the flow control device within the bronchial passageway; a seal coupled to the frame, the seal configured to seal against internal walls of the bronchial passageway; and a valve coupled to the frame, the valve having lips that define a variable-sized mouth through which fluid can flow through the valve, wherein the lips move away from one another to increase the size of the mouth in response to fluid flow in a first direction and move toward one another to decrease the size of the mouth in response to fluid flow in a second direction, and wherein the lips are at least partially spaced apart to define an open mouth when the valve is exposed to no fluid flow.

Problems solved by technology

Because of the increase in environmental pollutants, cigarette smoking, and other noxious exposures, the incidence of COPD has increased dramatically in the last few decades and now ranks as a major cause of activity-restricting or bed-confining disability in the United States.

It is known that emphysema and other pulmonary diseases reduce the ability of one or both lungs to fully expel air during the exhalation phase of the breathing cycle.

The problem is further compounded by the diseased, less elastic tissue that surrounds the very narrow airways that lead to the alveoli, which are the air sacs where oxygen-carbon dioxide exchange occurs.

The diseased tissue has less tone than healthy tissue and is typically unable to maintain the narrow airways open until the end of the exhalation cycle.

This traps air in the lungs and exacerbates the already-inefficient breathing cycle.

The trapped air causes the tissue to become hyper-expanded and no longer able to effect efficient oxygen-carbon dioxide exchange.

By taking up more of the pleural space, the hyper-expanded lung tissue reduces the amount of space available to accommodate the healthy, functioning lung tissue.

As a result, the hyper-expanded lung tissue causes inefficient breathing due to its own reduced functionality and because it adversely affects the functionality of adjacent healthy tissue.

However, such devices are still in the development stages.

Images